BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
